Champions Oncology Statistics
Total Valuation
CSBR has a market cap or net worth of $66.07 million. The enterprise value is $69.34 million.
| Market Cap | 66.07M |
| Enterprise Value | 69.34M |
Important Dates
The next estimated earnings date is Monday, July 22, 2024, after market close.
| Earnings Date | Jul 22, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
CSBR has 13.59 million shares outstanding. The number of shares has increased by 0.26% in one year.
| Shares Outstanding | 13.59M |
| Shares Change (YoY) | +0.26% |
| Shares Change (QoQ) | +0.72% |
| Owned by Insiders (%) | 25.56% |
| Owned by Institutions (%) | 41.85% |
| Float | 4.75M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 22.88 |
| PS Ratio | 1.34 |
| Forward PS | 1.23 |
| PB Ratio | n/a |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.41 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.60
| Current Ratio | 0.60 |
| Quick Ratio | 0.56 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -850.70% and return on invested capital (ROIC) is -168.98%.
| Return on Equity (ROE) | -850.70% |
| Return on Assets (ROA) | -32.60% |
| Return on Capital (ROIC) | -168.98% |
| Revenue Per Employee | $214,017 |
| Profits Per Employee | -$42,296 |
| Employee Count | 230 |
| Asset Turnover | 1.65 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, CSBR has paid $70,000 in taxes.
| Income Tax | 70,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -22.73% in the last 52 weeks. The beta is 0.41, so CSBR's price volatility has been lower than the market average.
| Beta (5Y) | 0.41 |
| 52-Week Price Change | -22.73% |
| 50-Day Moving Average | 4.84 |
| 200-Day Moving Average | 5.43 |
| Relative Strength Index (RSI) | 48.59 |
| Average Volume (20 Days) | 13,219 |
Short Selling Information
The latest short interest is 52,212, so 0.38% of the outstanding shares have been sold short.
| Short Interest | 52,212 |
| Short Previous Month | 53,184 |
| Short % of Shares Out | 0.38% |
| Short % of Float | 1.10% |
| Short Ratio (days to cover) | 3.36 |
Income Statement
In the last 12 months, CSBR had revenue of $49.22 million and -$9.73 million in losses. Loss per share was -$0.72.
| Revenue | 49.22M |
| Gross Profit | 19.74M |
| Operating Income | -9.61M |
| Pretax Income | -9.66M |
| Net Income | -9.73M |
| EBITDA | -7.67M |
| EBIT | -9.66M |
| Loss Per Share | -$0.72 |
Balance Sheet
The company has $4.47 million in cash and $7.74 million in debt, giving a net cash position of -$3.27 million or -$0.24 per share.
| Cash & Cash Equivalents | 4.47M |
| Total Debt | 7.74M |
| Net Cash | -3.27M |
| Net Cash Per Share | -$0.24 |
| Equity (Book Value) | -2.06M |
| Book Value Per Share | -0.15 |
| Working Capital | -8.77M |
Cash Flow
In the last 12 months, operating cash flow was -$5.01 million and capital expenditures -$1.71 million, giving a free cash flow of -$6.72 million.
| Operating Cash Flow | -5.01M |
| Capital Expenditures | -1.71M |
| Free Cash Flow | -6.72M |
| FCF Per Share | -$0.49 |
Margins
Gross margin is 40.09%, with operating and profit margins of -19.51% and -19.76%.
| Gross Margin | 40.09% |
| Operating Margin | -19.51% |
| Pretax Margin | -19.62% |
| Profit Margin | -19.76% |
| EBITDA Margin | -15.57% |
| EBIT Margin | -19.62% |
| FCF Margin | -13.65% |
Dividends & Yields
CSBR does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.26% |
| Shareholder Yield | -0.26% |
| Earnings Yield | -14.72% |
| FCF Yield | -10.17% |
Analyst Forecast
The average price target for CSBR is $7.50, which is 54.32% higher than the current price. The consensus rating is "Buy".
| Price Target | $7.50 |
| Price Target Difference | 54.32% |
| Analyst Consensus | Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | 13.17% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on August 12, 2015. It was a reverse split with a ratio of 1:12.
| Last Split Date | Aug 12, 2015 |
| Split Type | Reverse |
| Split Ratio | 1:12 |
Scores
CSBR has an Altman Z-Score of -2.79 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -2.79 |
| Piotroski F-Score | 3 |